Article Details
Retrieved on: 2022-02-03 07:44:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here